Tumor Biology

Last updated

Editors

Tumor Biology's founding editor-in-chief was William H. Fishman (La Jolla Cancer Research Foundation), who edited the journal along with Hidematsu Hirai (Hokkaido University) from 1980 to 1983. In 1984, A. Munro Neville (Ludwig Institute for Cancer Research) took over as editor-in-chief, and in 1995, he was replaced by Sabine von Kleist (Albert Ludwigs University of Freiburg). [5] In 1999, von Kleist retired, at which point she was replaced by Torgny Stigbrand (Umea University), [6] who was still the journal's editor as of May 2017. [7]

In May 2017, Science Insider reported that multiple scientists listed on the journal's website as being members of its editorial board had no affiliation with the journal. One scientist, German Nobel laureate Harald zur Hausen, told Science Insider that he did not know he was on the list, and that he did not recall having ever reviewed a paper for the journal. [7]

Retractions and delisting

In April 2017, Springer announced it was retracting 107 papers that had been published in Tumor Biology while they were publishing it. According to Retraction Watch, this made Tumor Biology the journal with the most retracted articles out of all the journals indexed by the Web of Science at the time. [8] The cited reason for the retractions was that the papers in question had been accepted on the basis of fake peer reviews. [9] Specifically, the authors of the now-retracted studies had supplied fraudulent email addresses to external reviewers which purportedly belonged to their "recommended reviewers". This led to these papers receiving fake reviews and eventually being published. [7] [10]

In response, the Ministry of Science and Technology of the People's Republic of China announced that it would investigate the retractions, as all 107 papers were co-authored by Chinese researchers. In July, the Ministry announced that, based on the results of its investigation, it would punish the Chinese researchers who co-authored the retracted papers with disciplinary actions, including banning some of them from conducting additional research. [2] In August, Clarivate Analytics announced that articles published in the journal after July 19, 2017, would no longer be included in the Web of Science. [11]

Related Research Articles

In academic publishing, a retraction is the action by which a published paper in an academic journal is removed from the journal.

<span class="mw-page-title-main">Hindawi (publisher)</span> Scientific and medical journal publisher

Hindawi is a publisher of peer-reviewed, open access, scientific journals currently active in scientific, technical, and medical (STM) literature. It was founded in 1997 in Cairo, Egypt, but purchased in 2021 by John Wiley & Sons, a publishing company based in the United States. The company has its headquarters in London, an office in Cairo, and a virtual office address in New York City.

<i>PLOS One</i> Peer-reviewed open-access scientific journal

PLOS One is a peer-reviewed open access mega journal published by the Public Library of Science (PLOS) since 2006. The journal covers primary research from any discipline within science and medicine. The Public Library of Science began in 2000 with an online petition initiative by Nobel Prize winner Harold Varmus, formerly director of the National Institutes of Health and at that time director of Memorial Sloan–Kettering Cancer Center; Patrick O. Brown, a biochemist at Stanford University; and Michael Eisen, a computational biologist at the University of California, Berkeley, and the Lawrence Berkeley National Laboratory.

The Journal of Clinical Oncology is a peer-reviewed medical journal published 3 times a month by the Lippincott Williams & Wilkins. It covers research on all aspects of clinical oncology. The journal was established in 1983 and the editor-in-chief is Jonathan W. Friedberg. JCO's Impact Factor is 44.544 as reported by Clarivate in its 2020 Journal Citation Reports.

MDPI is a publisher of open access scientific journals. Founded by Shu-Kun Lin as a chemical sample archive, it now publishes over 390 peer-reviewed, open access journals. MDPI is among the largest publishers in the world in terms of journal article output, and is the largest publisher of open access articles.

Evidence-Based Complementary and Alternative Medicine is a peer-reviewed open-access medical journal covering complementary and alternative medicine published by Hindawi Publishing Corporation.

Scientific Reports is a peer-reviewed open-access scientific mega journal published by Nature Portfolio, covering all areas of the natural sciences. The journal was established in 2011. The journal states that their aim is to assess solely the scientific validity of a submitted paper, rather than its perceived importance, significance, or impact.

Frontiers Media SA is a publisher of peer-reviewed, open access, scientific journals currently active in science, technology, and medicine. It was founded in 2007 by Kamila and Henry Markram, and has since expanded to other academic fields. Frontiers is based in Lausanne, Switzerland, with other offices in London, Madrid, Seattle and Brussels. In 2022, Frontiers employed more than 1,400 people, across 14 countries. All Frontiers journals are published under a Creative Commons Attribution License.

Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal. The journal was established in 2010 and is published by Impact Journals. The editors-in-chief are Mikhail Blagosklonny and Andrei V. Gudkov.

Moon Hyung-In is a professor at Dong-A University in Busan, South Korea. He is a member of the Department of Medicinal Biotechnology, and he earned his PhD in the Department of Pharmacy at Sungkyunkwan University in 2001.

<span class="mw-page-title-main">Who's Afraid of Peer Review?</span> Science article by John Bohannon

"Who's Afraid of Peer Review?" is an article written by Science correspondent John Bohannon that describes his investigation of peer review among fee-charging open-access journals. Between January and August 2013, Bohannon submitted fake scientific papers to 304 journals owned by fee-charging open access publishers. The papers, writes Bohannon, "were designed with such grave and obvious scientific flaws that they should have been rejected immediately by editors and peer reviewers", but 60% of the journals accepted them. The article and associated data were published in the 4 October 2013 issue of Science as open access.

<i>Cell Biochemistry and Biophysics</i> Academic journal

Cell Biochemistry and Biophysics is a peer-reviewed scientific journal covering all aspects of the biology of cells, especially their biochemistry and biophysics. It was established in 1979 as Cell Biophysics with Nicholas Catsimpoolas as founding editor-in-chief, obtaining its current name in 1996. The journal is published by Springer Science+Business Media and the editor-in-chief is Lawrence J. Berliner.

Douglas D. Taylor is an entrepreneur and former academic researcher in the field of extracellular vesicles.

Lorenzo Galluzzi is an Italian and French cell biologist best known for his experimental and conceptual contributions to the fields of cell death, autophagy, tumor metabolism and tumor immunology.

<i>Annual Review of Cancer Biology</i> Academic journal

The Annual Review of Cancer Biology is a peer-reviewed academic journal that publishes review articles about oncology. It published its first volume in 2017, making it the 47th journal published by the nonprofit Annual Reviews. Founded by Tyler Jacks and Charles L. Sawyers, it is currently edited by Laura Attardi and Scott A. Armstrong. It is content is broadly focused on cancer cell biology, tumorigenesis and cancer progression, and translational cancer science. The Annual Review of Cancer Biology is published open access under the Subscribe to Open (S2O) publishing model.

William Harold Fishman was a Canadian-American cancer researcher who taught at Tufts University from 1948 until his retirement in 1975. In 1976, with a $180,000 grant from the National Cancer Institute, he co-founded the La Jolla Cancer Research Foundation with his wife, Lillian. He was also the founding editor-in-chief of Tumor Biology, serving in this role from 1980 to 1983.

The Journal of Alloys and Compounds is a peer-reviewed scientific journal covering experimental and theoretical approaches to materials problems that involve compounds and alloys. It is published by Elsevier and the editor-in-chief is Hongge Pan, Livio Battezzati. It was the first journal established to focus specifically on a group of inorganic elements.

<i>Acta Medica Mediterranea</i> Academic journal

Acta Medica Mediterranea is a bimonthly peer-reviewed open-access medical journal. It was established in 1985 and is published by Editore Carbone. The editors-in-chief are Alberto Notarbartolo and Pasquale Mansueto.

<i>Journal of Crystal Growth</i> Academic journal

The Journal of Crystal Growth is a semi-monthly peer-reviewed scientific journal covering experimental and theoretical studies of crystal growth and its applications. It is published by Elsevier and the editor-in-chief is J. Derby.

References

  1. ↑ "Aims and Scope". Tumor Biology Website.
  2. 1 2 3 Normile, Dennis (2017-07-31). "China cracks down after investigation finds massive peer-review fraud". Science. Retrieved 2017-12-15.
  3. ↑ Stigbrand, Torgny (2017-01-01). "The rapidly changing landscape of scientific publishing". Tumor Biology. 39 (1): 1010428316687894. doi: 10.1177/1010428316687894 . ISSN   1010-4283. PMID   28121285.
  4. ↑ "Tumor Biology". 2016 Journal Citation Reports. Web of Science (Science ed.). Clarivate Analytics. 2017.
  5. ↑ Goldenberg, David M. (2012-06-01). "Introduction to this special issue on tumor targeting". Tumor Biology. 33 (3): 571–572. doi: 10.1007/s13277-012-0390-7 . ISSN   1010-4283. PMID   22492239.
  6. ↑ Mach, Jean-Pierre (1999). "Changing of the Guard at the Editorial Level!". Tumor Biology. 20 (6): 293. doi: 10.1159/000030092 . ISSN   1010-4283.
  7. 1 2 3 Feldwisch-Drentrup, Hinnerk (2017-05-18). "Journal that holds record for retracted papers also has a problem with editorial board members". Science. Retrieved 2017-12-15.
  8. ↑ Mandelbaum, Ryan (2017-04-23). "Report: Cancer Journal Retracts a Record Hundred and Seven Studies". Gizmodo UK. Retrieved 2017-12-15.
  9. ↑ "A new record: Major publisher retracting more than 100 studies from cancer journal over fake peer reviews - Retraction Watch". Retraction Watch. 2017-04-20. Retrieved 2017-12-15.
  10. ↑ Huang, Echo (2017-05-04). "It's surprisingly easy to game peer review, scientific publishing's most important method". Quartz. Retrieved 2017-12-15.
  11. ↑ "When a journal retracts 107 papers for fake reviews, it pays a price". Retraction Watch. 2017-08-16. Retrieved 2017-12-15.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.